PHILLIPS T DANNY 4

What Happened
T. Danny Phillips, a director of Caris Life Sciences (CAI), was issued 3,739 shares on 2026-02-26 as an award/compensation (transaction code A). The shares were valued at $20.06 each, for a total reported value of $75,004. This issuance was compensation (shares issued in lieu of cash retainer fees), not an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-02-26 at $20.06 per share; total value $75,004.
• Transaction type: Award/Grant (code A) — shares issued in lieu of 2025 board retainer cash fees.
• Method: Number of shares was calculated by dividing the cash retainer by the ten-trading-day VWAP through and including Feb 25, 2026 (per footnote).
• Shares owned after transaction: Not disclosed in the provided filing.
• Filing date: Report filed 2026-02-27 for the 2026-02-26 transaction — no late filing indicated.

Context
This was a compensation issuance rather than a purchase or sale. Shares issued in lieu of cash do not necessarily signal the insider’s view of the company’s stock — they reflect routine director compensation.